Unicycive Therapeutics, Inc.UNCYNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-28.65M
↓ 179% below average
Average (6y)
$-10.26M
Historical baseline
Range
High:$-775000.00
Low:$-28.65M
CAGR
+82.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-28.65M | -56.6% |
| 2023 | $-18.30M | -16.9% |
| 2022 | $-15.65M | -170.1% |
| 2021 | $-5.80M | -297.3% |
| 2020 | $-1.46M | -24.1% |
| 2019 | $-1.18M | -51.7% |
| 2018 | $-775000.00 | - |